CClinicalTrials.gg
TerminatedNCT03113877Updated Dec 6, 2018

Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS)

An observational study in Cornelia de Lange Syndrome, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2018-12-06.

Sponsored by Mayo Clinic · Observational

Why this study was terminated
Difficulty in recruitment, Funding has run out.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1
Ages
8 Years to 18 Years
Sex
All
01

Study summary

Based on survey data, individuals with Cornelia de Lange Syndrome (CdLS) often experience symptoms of autonomic dysfunction however there are no reported studies in which these patients have had objective testing of the autonomic nervous system. This is a pilot study in which patients with CdLS will undergo the standard clinical testing for autonomic dysfunction with a autonomic reflex screen and thermoregulatory sweat test.

02

Conditions studied

  • Cornelia de Lange Syndrome

Browse trials for

03

In context

Syndrome

9,217 studies on the registry are indexed under Syndrome; 1,031 are open to participants now.

This study's enrollment of 1 is below the median of 102 across 2,209 observational studies indexed under Syndrome.

Browse Syndrome studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with CDLS reached through national distribution list through the CdLS Foundation with an invitation to volunteer.

Inclusion criteria

  • Pediatric patients (aged 8-17 years of age) with Cornelia de Lange syndrome.
  • Consent obtained from responsible guardian.

Exclusion criteria

Exclusion Criteria:

  • Patients less than age 8 or 18 and older
  • Female patients known to be pregnant
  • Individuals not thought to be able to tolerate the testing.
  • Concomitant therapy with anticholinergic, alpha-adrenergic antagonists, beta-adrenergic antagonists or other medications which could interfere with autonomic testing. Patients may participate if the potentially interfering medication is held for five half-lives prior to the study
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1 participant (actual)
Patient registry
No

Groups and cohorts

  • Clinical Testing for Autonomic Dysfunction

    COMPASS-31 Survey completion. Autonomic Reflex Screen. Thermoregulatory Swear Test.

    Other: Autonomic Dysfunction Testing

Interventions

  • OtherAutonomic Dysfunction Testing

    The participants with CdLS will complete the COMPASS-31 survey and will complete standard clinical testing for autonomic dysfunction including an autonomic reflex screen (tilt table and quantitative sudomotor axon reflex testing) and thermoregulatory sweat test (TST).

06

What researchers measure

Primary outcomes

  1. Number of patients who tolerated 70 degree head up tilt table test

    Patients tolerating at least 5 minutes of tilt table

    Time frame: 1 year

  2. Number of patients who show evidence of dysautonomia

    Dysautonomia measured by excessive heart rate (\>40 bpm) on a tilt table test or reduced sweating on a thermoregulatory sweat test.

    Time frame: 1 year

  3. Number of patients who tolerated thermoregulatory sweat test

    Patients tolerating at least 15 minutes of thermoregulatory sweat test

    Time frame: 1 year

07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03113877
Lead sponsor
Mayo Clinic
Responsible party
Amie E. Jones, M.D. (PI, Mayo Clinic) — Principal investigator
First posted
Apr 14, 2017
Start date
Aug 2016
Primary completion
Sep 1, 2017
Completion
Sep 1, 2017
Last update
Dec 6, 2018

Study contacts

Amie E Jones, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion